Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aaby

Showing results (181-190 of 221) with videos related to

Pageof 23
Sort By:
Journal of Clinical Microbiology|October 4, 2000
Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic vibrio cholerae O1 strains isolated in Guinea-BissauA Dalsgaard, A Forslund, A Petersen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2011
Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspectsA Porskrog, M Bjerregaard-Andersen, I Oliveira, et al.
The Journal of Pediatrics|June 1, 1993
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rateP Aaby, K Knudsen, H Whittle, et al.
Lancet (London, England)|March 29, 1997
9-year HIV-2-associated mortality in an urban community in Bissau, west AfricaA G Poulsen, P Aaby, O Larsen, et al.
Vaccine|March 3, 2001
Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccineM L Garly, C Balé, C L Martins, et al.
Epidemiology and Infection|April 1, 1994
Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-upP Aaby, I M Lisse, H Whittle, et al.
Epidemiology and Infection|June 15, 2007
Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-BissauW P Schmidt, M Schim Van Der Loeff, P Aaby, et al.
The Pediatric Infectious Disease Journal|September 24, 1999
Community-based randomized controlled trial of reduced osmolarity oral rehydration solution in acute childhood diarrheaP Valentiner-Branth, H Steinsland, H K Gjessing, et al.
Vaccine|November 29, 2016
A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participantsS Byberg, S M Thysen, A Rodrigues, et al.
Annals of Tropical Paediatrics|December 6, 2001
Seven years' experience with Cryptosporidium parvum in Guinea-Bissau, West AfricaM Perch, M Sodemann, M S Jakobsen, et al.
Pageof 23

Showing results (181-190 of 221) with videos related to

Sort By:
Pageof 23
Journal of Clinical Microbiology|October 4, 2000
Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic vibrio cholerae O1 strains isolated in Guinea-BissauA Dalsgaard, A Forslund, A Petersen, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|March 15, 2011
Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspectsA Porskrog, M Bjerregaard-Andersen, I Oliveira, et al.
The Journal of Pediatrics|June 1, 1993
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rateP Aaby, K Knudsen, H Whittle, et al.
Lancet (London, England)|March 29, 1997
9-year HIV-2-associated mortality in an urban community in Bissau, west AfricaA G Poulsen, P Aaby, O Larsen, et al.
Vaccine|March 3, 2001
Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccineM L Garly, C Balé, C L Martins, et al.
Epidemiology and Infection|April 1, 1994
Long-term survival in trial of medium-titre Edmonston-Zagreb measles vaccine in Guinea-Bissau: five-year follow-upP Aaby, I M Lisse, H Whittle, et al.
Epidemiology and Infection|June 15, 2007
Behaviour change and competitive exclusion can explain the diverging HIV-1 and HIV-2 prevalence trends in Guinea-BissauW P Schmidt, M Schim Van Der Loeff, P Aaby, et al.
The Pediatric Infectious Disease Journal|September 24, 1999
Community-based randomized controlled trial of reduced osmolarity oral rehydration solution in acute childhood diarrheaP Valentiner-Branth, H Steinsland, H K Gjessing, et al.
Vaccine|November 29, 2016
A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participantsS Byberg, S M Thysen, A Rodrigues, et al.
Annals of Tropical Paediatrics|December 6, 2001
Seven years' experience with Cryptosporidium parvum in Guinea-Bissau, West AfricaM Perch, M Sodemann, M S Jakobsen, et al.
Pageof 23